Skip to main navigation
Skip to main content
  • Email Alerts
  • News
  • Lilly.com
  • Stock Info
    Expand mega menu
    Expand submenu
    Stock Info
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Dividends & Stock Splits
  • Webcasts & Presentations
  • Financials
    Expand mega menu
    Expand submenu
    Financials
    • SEC Filings
    • Annual Reports
    • Quarterly Results
    • Key Ratios
    • Interactive Financials
    • Debt Securities
  • Individual Investors
  • Resources
    Expand mega menu
    Expand submenu
    Resources
    • Clinical Development Pipeline
    • Current Medicines
    • Executive Committee
    • Key Facts
    • 2021 Year in Review
    • ESG Report
  • Email Alerts
  • News
  • Lilly.com

Investors

Investors

Latest News

February 2, 2023

Lilly Reports Fourth-Quarter 2022 Financial Results, Core Business Growth and Pipeline Advancements Support Strong Long-Term Outlook

January 27, 2023

U.S. FDA Approves Jaypirca™ (pirtobrutinib), the First and Only Non-Covalent (Reversible) BTK Inhibitor, for Adult Patients with Relapsed or Refractory Mantle Cell Lymphoma After at Least Two Lines of Systemic Therapy, Including a BTK Inhibitor

January 26, 2023

Lilly Supports Direct Relief's Efforts to Expand Access to Medicines by Improving Cold Chain Capacity

View All

Upcoming Events

February 2, 2023 at 10:00 AM EST

Q4 2022 Earnings Call

February 9, 2023 at 10:10 AM EST

Guggenheim Oncology Conference

April 27, 2023 at 10:00 AM EDT

Q1 2023 Earnings Call

August 8, 2023 at 9:00 AM EDT

Q2 2023 Earnings Call

October 31, 2023 at 9:00 AM EDT

Q3 2023 Earnings Call

View All
two people talking in library with laptop

Clinical Development Pipeline

Learn More
"when we fulfill our purpose, we help others fulfill theirs" in white letters on a red background

Quarterly Results

View Results
2021 Year in Review

2021 Year in Review

View This Report
people talking at the table of a team building lunch with red balloons

Key Ratios

Key Financial Ratios
"when we fulfill our purpose, we help others fulfill theirs" in white letters on a red background

ESG Report

Learn More
"when we fulfill our purpose, we help others fulfill theirs" in white letters on a red background

Latest ESG Developments

View Stories
wide shot of two scientists in lab

Investor Email Alerts

Sign up to receive email alerts for various types of investor content.

Diversity
Contact
Suppliers
Login
Terms of Use
Privacy Statement
Accessibility Statement
Sitemap

To speak to customer support:
Call (800) 545-5979

Copyright © 2023 Eli Lilly and Company. All rights reserved.
Twitter Facebook Instagram LinkedIn YouTube
Terms of Use Privacy Statement Accessibility Statement Sitemap